| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |